Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung

MeSH terms

• Adult
• Aged
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Daunorubicin / analogs & derivatives*
• Drug Evaluation
• Female
• Humans
• Lung Neoplasms / drug therapy*
• Male
• Menogaril
• Middle Aged
• Nogalamycin / adverse effects
• Nogalamycin / analogs & derivatives
• Nogalamycin / therapeutic use*